NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/06/2026
Voltar para busca
Dado oficial do USPTO
EPKIN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
16/06/2026
Tipo de marca
Verbal
Classes Nice
9, 42, 44
Data de depósito
22/10/2024
Data de registro
16/06/2026
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/06/2026
Última transação
16/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Paris, FR
Examinador
LEE, OLIVIA SUNMIN
Unidade examinadora
O10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
EPKIN
Representantes
Andrew D. Bochner Bochner PLLC
Classificação técnica
Classes Nice
Classe 9Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable artificial intelligence and machine learning software for developingrunning and analyzing algorithms that are able to learn to analyzeclassifytake actions in response to exposure to data; Downloadable artificial intelligence software for healthcare for developingrunning and analyzing algorithms that are able to learn to analyzeclassifytake actions in response to exposure to data; Downloadable computer software and programs using artificial intelligence for data and software processinggenerationunderstanding and analysis; downloadable computer programs and downloadable computer software for artificial intelligencecomputer software for developingrunning and analyzing algorithms that are able to learn to analyzeclassifytake actions in response to exposure to data; downloadable computer software for simulation environments for the purpose of testing artificial intelligence agentsalgorithms or programs; Downloadable computer software and programs for diagnosing health conditionprescribing treatments and writing prescriptionsdesigning clinical tests and forecasting clinical test resultssearching for clinical trial participantsanalysing medical imagesanalysing datadeveloping pharmaceuticals and chemical compounds
Classe 42
Platform as a service (PAAS) featuring computer software platforms using artificial intelligence for activities relating to experimentationdesignresearch and development of therapeutic strategies and pharmaceutical specialtiesbiology and biochemistry; Research in the field of artificial intelligence technology; Technology consultation in the field of artificial intelligence; Software as a service (SaaS) featuring software for diagnosing health conditionprescribing treatments and writing prescriptionsdesigning clinical tests and forecasting clinical test resultssearching for clinical trial participantsanalysing medical imagesanalysing datadeveloping pharmaceuticals and chemical compounds; Scientific and technological servicesexperimentation being testingdesignresearch and development of therapeutic strategies and pharmaceutical specialtiesbiology and biochemistry in the field of oncology; Advisory services relating to scientific research; Scientific research; Engineering services; Technical consultancy services relating to computer programming; Research and development services in the field of engineering; Development of computer programs for others; Software design and development; Consultancy relating to research and development in the field of therapeutics solutions and pharmaceutical products; Scientific research in the nature of conducting clinical trials for others for pharmaceutical products; Scientific research in the nature of conducting clinical trials in the field of oncology; Scientific research relating to biology; Research and development in the field of biochemistry
Classe 44
Medical services; Medical diagnostic services; Pharmaceutical advice; Providing medical information to medical professionals in the form of reports in the field of oncology; Medical services in the field of oncology
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
16/06/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/04/2026
PUBO
PUBLISHED FOR OPPOSITION
28/04/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/03/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/03/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/12/2025
GNRT
NON-FINAL ACTION E-MAILED
09/12/2025
CNRT
NON-FINAL ACTION WRITTEN
09/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/10/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/08/2025
GNRT
NON-FINAL ACTION E-MAILED
18/08/2025
CNRT
NON-FINAL ACTION WRITTEN
18/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2025
GNRT
NON-FINAL ACTION E-MAILED
12/05/2025
CNRT
NON-FINAL ACTION WRITTEN
12/05/2025
DOCK
ASSIGNED TO EXAMINER
24/04/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/04/2025
NWAP
NEW APPLICATION ENTERED
22/10/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EPKIN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.